Marjolein Geurts
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Exploring the landscape of targetable alterations in patients with glioblastoma.
Journal: Nature reviews. Clinical oncology
Published: July 20, 2026
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.
Journal: Neuro-oncology
Published: May 05, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions.
Journal: Neuro-oncology
Published: March 09, 2026
Neurological complications induced by checkpoint inhibitors: characterising the clinical spectra.
Journal: BMJ neurology open
Published: February 09, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.
Journal: Neuro-oncology advances
Published: January 13, 2026
Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.
Journal: Journal of neuro-oncology
Published: January 08, 2026
Drawing parallels between amyloid PET in Alzheimer's disease and amino acid PET in primary and secondary brain tumors.
Journal: Neuro-oncology advances
Published: October 31, 2025
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas.
Journal: Neuro-oncology
Published: July 28, 2025
Genomic distinctions in adolescent and young adult cancer: A comprehensive review.
Journal: Cancer treatment reviews
Published: July 24, 2025
T cell immunity in glioma and potential implications for immunotherapy: a systematic review.
Journal: Neuro-oncology
Published: July 01, 2025
Last Updated: 09/26/2026